Kyndryl's Financial Targets Seen as Too Lofty -- Market Talk

Dow Jones04-20 22:28

1028 ET - Kyndryl's two-year targets appear to be too aggressive, BMO Capital Markets analysts say in a research note. While Kyndryl has made progress growing its consulting business and is well positioned to continue gaining share, the analysts say they are cautious on the overall market. "We think that market demand remains muted in the near-term and generative AI impact to long-term market growth creates uncertainty," they write. At the same time, the growth across Kendyrl's consulting business doesn't seem to be enough to offset declining revenue across its managed services business. As a result: "We do not expect Kyndryl to deliver on its previously issued FY28 financial targets," the analysts say. BMO launches coverage of Kyndryl with a market perform rating and $15 target price. (connor.hart@wsj.com)

 

(END) Dow Jones Newswires

April 20, 2026 10:28 ET (14:28 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment